Literature DB >> 30712369

Evidence for kinesio taping in management of myofascial pain syndrome: a systematic review and meta-analysis.

Xue-Feng Zhang1, Lin Liu2, Bin-Bin Wang1, Xu Liu3, Ping Li4.   

Abstract

OBJECTIVE: The aim of this study was to evaluate the effectiveness of kinesio taping for managing myofascial pain syndrome in terms of pain intensity, pressure pain threshold, range of motion, muscle strength and disability. DATA SOURCES: PubMed, EBSCO, ScienceDirect, Web of Science, Cochrane Library and Physiotherapy Evidence Databases were searched from database inception to November 2018.
METHODS: Randomized controlled trials (RCTs) that used kinesio taping as the main treatment protocol for participants diagnosed with myofascial pain syndrome were included. Two reviewers independently screened articles, scored methodological quality using Cochrane risk-of-bias tool and extracted data. The primary outcomes were pain intensity, pressure pain threshold and range of motion at post-intervention and follow-up. The secondary outcomes were muscle strength and disability at post-intervention and follow-up. DATA SYNTHESIS: Meta-analyses of 20 RCTs involving 959 patients showed that kinesio taping was more effective than other treatments in reducing pain intensity (mean difference (MD) = 1.06 cm, 95% confidence interval (CI): -1.66 to -0.46 cm, P = 0.006) and increasing range of motion (standardized mean difference (SMD) = 0.26, 95% CI: 0.09 to 0.43, P = 0.003) at post-intervention. Kinesio taping was also superior to other non-invasive techniques in relieving pain intensity at follow-up (MD = -0.68 cm, 95% CI: -1.22 to -0.13 cm, P = 0.02). However, there was no detectable effect on disability or function.
CONCLUSION: Statistical evidence showed that kinesio taping could be recommended to relieve pain intensity and range of motion for patients with myofascial pain syndrome at post-intervention.

Entities:  

Keywords:  Kinesio taping; myofascial pain syndromes; randomized controlled trials; range of motion; systematic review

Mesh:

Year:  2019        PMID: 30712369     DOI: 10.1177/0269215519826267

Source DB:  PubMed          Journal:  Clin Rehabil        ISSN: 0269-2155            Impact factor:   3.477


  7 in total

Review 1.  Molecular Mechanisms Underlying the Pain-Relieving Effects of Extracorporeal Shock Wave Therapy: A Focus on Fascia Nociceptors.

Authors:  Larisa Ryskalin; Gabriele Morucci; Gianfranco Natale; Paola Soldani; Marco Gesi
Journal:  Life (Basel)       Date:  2022-05-17

2.  The Effectiveness of the Polarized Low-Level Laser in the Treatment of Patients With Myofascial Trigger Points in the Trapezius Muscles.

Authors:  Dadollah Shahimoridi; Seyed Ali Shafiei; Bahram Yousefian
Journal:  J Lasers Med Sci       Date:  2020-01-18

Review 3.  Effectiveness of kinesiology taping on the functions of upper limbs in patients with stroke: a meta-analysis of randomized trial.

Authors:  Yuxin Wang; Xiguang Li; Cuiyun Sun; Rong Xu
Journal:  Neurol Sci       Date:  2022-03-26       Impact factor: 3.830

4.  The effects of kinesiology taping on experimentally-induced thermal and mechanical pain in otherwise pain-free healthy humans: A randomised controlled repeated-measures laboratory study.

Authors:  Gourav Banerjee; Michelle Briggs; Mark I Johnson
Journal:  PLoS One       Date:  2019-12-10       Impact factor: 3.240

Review 5.  Taping for conditions of the musculoskeletal system: an evidence map review.

Authors:  Zachary A Cupler; Muhammad Alrwaily; Emily Polakowski; Kevin S Mathers; Michael J Schneider
Journal:  Chiropr Man Therap       Date:  2020-09-15

6.  Kinesiology Tape: A Descriptive Survey of Healthcare Professionals in the United States.

Authors:  Scott W Cheatham; Russell T Baker; Thomas E Abdenour
Journal:  Int J Sports Phys Ther       Date:  2021-06-01

7.  Effects of Different Kinesio-Taping Applications for Delayed Onset Muscle Soreness after High-Intensity Interval Training Exercise: A Randomized Controlled Trial.

Authors:  Bao-Lien Hung; Chen-Yu Sun; Nai-Jen Chang; Wen-Dien Chang
Journal:  Evid Based Complement Alternat Med       Date:  2021-06-21       Impact factor: 2.629

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.